Compare FELE & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FELE | TMDX |
|---|---|---|
| Founded | 1944 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.9B |
| IPO Year | N/A | 2019 |
| Metric | FELE | TMDX |
|---|---|---|
| Price | $96.04 | $127.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $107.00 | ★ $134.80 |
| AVG Volume (30 Days) | 233.3K | ★ 853.2K |
| Earning Date | 10-28-2025 | 10-29-2025 |
| Dividend Yield | ★ 1.10% | N/A |
| EPS Growth | N/A | ★ 170.70 |
| EPS | ★ 3.07 | 2.54 |
| Revenue | ★ $2,110,140,000.00 | $566,354,000.00 |
| Revenue This Year | $7.80 | $38.84 |
| Revenue Next Year | $4.77 | $20.43 |
| P/E Ratio | ★ $31.30 | $50.00 |
| Revenue Growth | 5.06 | ★ 41.20 |
| 52 Week Low | $78.87 | $55.00 |
| 52 Week High | $109.97 | $156.00 |
| Indicator | FELE | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 55.03 | 44.70 |
| Support Level | $92.20 | $133.50 |
| Resistance Level | $97.44 | $142.95 |
| Average True Range (ATR) | 2.16 | 6.94 |
| MACD | 0.30 | -1.88 |
| Stochastic Oscillator | 69.99 | 7.03 |
Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.